Caris Life Sciences, Inc. Common Stock insider trading
CAIfinancial statementsForm 4 filings on EDGAR80 transactions since Nov 16, 2024
From August 19, 2026 to November 16, 2026, 0 insiders at Caris Life Sciences, Inc. Common Stock bought $0 of stock in the open market, and 3 sold $27M. Officers and directors accounted for $0 of purchases and $27M of sales. The last reported transaction was an open-market sale by Denton John Russel on September 22, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through September 23, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $27MAug 19, 2026 – Nov 16, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 13, 2026. Insider data through Nov 16, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
80 transactions from November 16, 2024 to November 16, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Denton John Russel | See Remarks | open-market sale | 7,500 | $31.82 | $239K | 174,855 | Sep 23, 2026 |
| Sep 17, 2026 | Brille Brian J | See Remarks, Director | option exercise | 400,000 | $2.44 | $976K | 630,303 | Sep 17, 2026 |
| Sep 17, 2026 | Brille Brian J | See Remarks, Director | open-market sale | 400,000 | $30.33 | $12M | 230,303 | Sep 17, 2026 |
| Sep 4, 2026 | Spetzler David Baxley | President | option exercise | 250,000 | $2.44 | $610K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Spetzler David Baxley | President | open-market sale | 119,212 | $24.76 | $3M | 1M | Sep 4, 2026 |
| Sep 3, 2026 | Spetzler David Baxley | President | option exercise | 1M | $2.44 | $2M | 2M | Sep 4, 2026 |
| Sep 3, 2026 | Spetzler David Baxley | President | open-market sale | 393,100 | $24.76 | $10M | 1M | Sep 4, 2026 |
| Sep 3, 2026 | Spetzler David Baxley | President | open-market sale | 84,900 | $25.32 | $2M | 1M | Sep 4, 2026 |
| Aug 14, 2026 | Castleman Peter M | Director | award | 13,192 | $0.00 | — | 29,321 | Aug 14, 2026 |
| Aug 14, 2026 | Phillips T Danny | Director | award | 13,192 | $0.00 | — | 133,060 | Aug 14, 2026 |
| Aug 14, 2026 | Minor Lloyd | Director | award | 13,192 | $0.00 | — | 31,813 | Aug 14, 2026 |
| Aug 14, 2026 | Gilliam Joseph E | Director | award | 13,192 | $0.00 | — | 29,321 | Aug 14, 2026 |
| Aug 14, 2026 | Fredrickson David Paul | Director | award | 13,192 | $0.00 | — | 31,813 | Aug 14, 2026 |
| Aug 14, 2026 | Vacirca Jeff L | Director | award | 13,192 | $0.00 | — | 62,863 | Aug 14, 2026 |
| Aug 14, 2026 | Johansen Laura I | Director | award | 13,192 | $0.00 | — | 343,897 | Aug 14, 2026 |
| Aug 14, 2026 | Halbert Jon | Director | award | 13,192 | $0.00 | — | 131,813 | Aug 14, 2026 |
| May 29, 2026 | Poste George | Director | award | 1,600 | $15.62 | $25K | 17,729 | Jun 2, 2026 |
| May 29, 2026 | Knowles Jonathan Kenneth Charles | Director | award | 1,600 | $15.62 | $25K | 308,979 | Jun 2, 2026 |
| May 15, 2026 | Halbert Jon | Director | open-market buyindirect | 68,000 | $14.56 | $990K | 704,598 | Jul 13, 2026 |
| May 15, 2026 | Denton John Russel | See Remarks | tax withholding | 6,047 | $15.25 | $92K | 181,515 | May 18, 2026 |
| May 15, 2026 | Power Luke Thomas | See Remarks | tax withholding | 9,771 | $15.25 | $149K | 153,771 | May 18, 2026 |
| May 15, 2026 | Spetzler David Baxley | President | tax withholding | 13,856 | $15.25 | $211K | 530,083 | May 18, 2026 |
| May 15, 2026 | Brille Brian J | See Remarks, Director | tax withholding | 13,987 | $15.25 | $213K | 230,303 | May 18, 2026 |
| May 15, 2026 | Halbert David D | See Remarks, Director, 10% owner | tax withholding | 40,712 | $15.25 | $621K | 3M | May 18, 2026 |
| May 11, 2026 | Vacirca Jeff L | Director | open-market buy | 31,050 | $16.15 | $501K | 49,671 | May 12, 2026 |
| Mar 6, 2026 | Power Luke Thomas | See Remarks | award | 63,971 | $0.00 | — | 163,542 | Mar 10, 2026 |
| Mar 6, 2026 | Denton John Russel | See Remarks | award | 63,971 | $0.00 | — | 187,562 | Mar 10, 2026 |
| Mar 6, 2026 | Spetzler David Baxley | President | award | 83,162 | $0.00 | — | 543,939 | Mar 10, 2026 |
| Mar 6, 2026 | Brille Brian J | See Remarks, Director | award | 83,162 | $0.00 | — | 244,290 | Mar 10, 2026 |
| Mar 6, 2026 | Halbert David D | See Remarks, Director, 10% owner | award | 320,112 | $0.00 | — | 3M | Mar 10, 2026 |
| Feb 26, 2026 | Minor Lloyd | Director | award | 2,492 | $20.06 | $50K | 18,621 | Mar 2, 2026 |
| Feb 26, 2026 | Vacirca Jeff L | Director | award | 2,492 | $20.06 | $50K | 18,621 | Feb 27, 2026 |
| Feb 26, 2026 | Fredrickson David Paul | Director | award | 2,492 | $20.06 | $50K | 18,621 | Feb 27, 2026 |
| Feb 26, 2026 | Halbert Jon | Director | award | 2,492 | $20.06 | $50K | 118,621 | Feb 27, 2026 |
| Feb 26, 2026 | Phillips T Danny | Director | award | 3,739 | $20.06 | $75K | 119,868 | Feb 27, 2026 |
| Feb 26, 2026 | Castleman Peter M | Director | award | 5,509 | $20.06 | $111K | 24,138 | Feb 27, 2026 |
| Jan 9, 2026 | Castleman Peter M | Director | option exercise | 2,500 | $18.60 | $47K | 18,629 | Jan 13, 2026 |
| Dec 11, 2025 | Power Luke Thomas | See Remarks | option exercise | 24,750 | $2.44 | $60K | 124,321 | Dec 12, 2025 |
| Dec 11, 2025 | Power Luke Thomas | See Remarks | open-market sale10b5-1 | 1,400 | $27.16 | $38K | 99,571 | Dec 12, 2025 |
| Dec 11, 2025 | Power Luke Thomas | See Remarks | open-market sale10b5-1 | 60,850 | $26.56 | $2M | 100,971 | Dec 12, 2025 |
| Dec 11, 2025 | Power Luke Thomas | See Remarks | option exercise | 37,500 | $2.44 | $92K | 161,821 | Dec 12, 2025 |
| Dec 11, 2025 | Brille Brian J | See Remarks, Director | gift | 650 | $0.00 | — | 161,128 | Dec 12, 2025 |
| Dec 10, 2025 | Brille Brian J | See Remarks, Director | gift | 650 | $0.00 | — | 161,778 | Dec 12, 2025 |
| Nov 7, 2025 | Denton John Russel | See Remarks | open-market buyindirect | 4,184 | $24.09 | $101K | 9,184 | Nov 10, 2025 |
| Nov 7, 2025 | Spetzler David Baxley | President | open-market buy | 400 | $23.85 | $10K | 460,777 | Nov 10, 2025 |
| Sep 11, 2025 | Phillips T Danny | Director | option exercise | 100,000 | $2.44 | $244K | 116,129 | Sep 12, 2025 |
| Aug 11, 2025 | Poste George | Director | tax withholding | 91,495 | $29.75 | $3M | 220,237 | Aug 13, 2025 |
| Aug 11, 2025 | Poste George | Director | tax withholding | 48,022 | $29.75 | $1M | 311,732 | Aug 13, 2025 |
| Aug 11, 2025 | Poste George | Director | option exercise | 125,000 | $2.44 | $305K | 359,754 | Aug 13, 2025 |
| Aug 11, 2025 | Spetzler David Baxley | President | tax withholding | 63,509 | $29.75 | $2M | 460,377 | Aug 13, 2025 |
Who the insiders are
Everyone who reported a transaction since November 16, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Spetzler David Baxley | President | Sep 4, 2026 | option exercise | 1M | — | $15M (3) | 0 of 3 |
| Brille Brian J | See Remarks, Director | Sep 17, 2026 | option exercise | 630,303 | — | $12M (1) | 0 of 1 |
| Power Luke Thomas | See Remarks | May 15, 2026 | tax withholding | 153,771 | — | $2M (2) | 2 of 2 |
| Halbert Jon | Director | Aug 14, 2026 | award | 131,813 | $990K (1) | — | — |
| Vacirca Jeff L | Director | Aug 14, 2026 | award | 62,863 | $501K (1) | — | — |
| Denton John Russel | See Remarks | Sep 22, 2026 | open-market sale | 174,855 | — | $239K (1) | 0 of 1 |
| TSSP Sub-Fund HoldCo LLC | — | Jun 20, 2025 | option exercise | — | — | — | — |
| Castleman Peter M | Director | Aug 14, 2026 | award | 29,321 | — | — | — |
| Poste George | Director | May 29, 2026 | award | 17,729 | — | — | — |
| Phillips T Danny | Director | Aug 14, 2026 | award | 133,060 | — | — | — |
| Halbert David D | See Remarks, Director, 10% owner | May 15, 2026 | tax withholding | 3M | — | — | — |
| Caris Halbert, L.P. | Director, 10% owner | Jun 20, 2025 | conversion | 2M | — | — | — |
| Minor Lloyd | Director | Aug 14, 2026 | award | 31,813 | — | — | — |
| Fredrickson David Paul | Director | Aug 14, 2026 | award | 31,813 | — | — | — |
| Gilliam Joseph E | Director | Aug 14, 2026 | award | 29,321 | — | — | — |
| Johansen Laura I | Director | Aug 14, 2026 | award | 343,897 | — | — | — |
| Knowles Jonathan Kenneth Charles | Director | May 29, 2026 | award | 308,979 | — | — | — |
| Williams Robert M JR | 10% owner | Jun 20, 2025 | conversion | — | — | — | — |
| ADAPT I Ltd. | 10% owner | Jun 20, 2025 | conversion | — | — | — | — |
Questions
Are Caris Life Sciences, Inc. Common Stock insiders buying or selling?
Over the twelve months to November 16, 2026, 4 insiders at Caris Life Sciences, Inc. Common Stock sold $29M of stock in the open market, all by officers and directors, and 2 insiders bought $1M, all by officers and directors. Net, insiders sold $27M. Only open-market purchases and sales are counted.
Who sold the most Caris Life Sciences, Inc. Common Stock stock in the last year?
Spetzler David Baxley (President) sold $15M in 3 open-market sales over the twelve months to November 16, 2026.
Do Caris Life Sciences, Inc. Common Stock executives sell under 10b5-1 plans?
2 of the 7 open-market sales in the last twelve months (29%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Caris Life Sciences, Inc. Common Stock
- Caris Life Sciences, Inc. Common Stock financial statements
- 1 tracked fund holding CAI
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.